Table 4.

Multivariate model for the relative risk of treatment failure

Variable	Hazard ratio	95% CI	P
Treatment with AS/SP vs SP	0.2	0.1–0.6	0.004
Age > 7 years vs. age ≤ 7 years	0.3	0.1–0.9	0.033
Presence of a quintuple mutation vs. fewer mutations	3.2	1.3–7.5	0.009
Temperature Day 0 (°C)	1.5	1.1–2.2	0.020

SP: sulphadoxine-pyrimethamine

AS/SP: artesunate/sulphadoxine-pyrimethamine